STRYKER CORP Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
STRYKER CORP (SYK) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $23.99 billion as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-07-31
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $23.99B.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $22.98B.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $22.42B.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $21.79B.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $23.99B 10-Q · filed 2026-07-31 |
| 2026-03-31 | $22.98B 10-Q · filed 2026-05-11 |
| 2025-12-31 | $22.42B 10-Q · filed 2026-07-31 |
| 2025-09-30 | $21.79B 10-Q · filed 2025-10-31 |
| 2025-06-30 | $21.19B 10-Q · filed 2026-07-31 |
| 2025-03-31 | $20.93B 10-Q · filed 2026-05-11 |
| 2024-12-31 | $20.63B 10-K · filed 2026-02-11 |
| 2024-09-30 | $20.15B 10-Q · filed 2025-10-31 |
| 2024-06-30 | $19.76B 10-Q · filed 2025-08-01 |
| 2024-03-31 | $19.17B 10-Q · filed 2025-05-02 |
| 2023-12-31 | $18.59B 10-K · filed 2026-02-11 |
| 2023-09-30 | $17.91B 10-Q · filed 2024-10-30 |
| 2023-06-30 | $17.36B 10-Q · filed 2024-07-31 |
| 2023-03-31 | $16.89B 10-Q · filed 2024-05-01 |
| 2022-12-31 | $16.62B 10-K · filed 2025-02-12 |
| 2022-09-30 | $16.46B 10-Q · filed 2023-11-03 |
| 2022-06-30 | $15.67B 10-Q · filed 2023-08-04 |
| 2022-03-31 | $15.05B 10-Q · filed 2023-05-02 |
| 2021-12-31 | $14.88B 10-K · filed 2024-02-14 |
| 2021-09-30 | $14.18B 10-Q · filed 2022-11-01 |
| 2021-06-30 | $13.82B 10-Q · filed 2022-07-27 |
| 2021-03-31 | $13.50B 10-Q · filed 2022-04-29 |
| 2020-12-31 | $13.08B 10-K · filed 2023-02-10 |
| 2020-09-30 | $12.99B 10-Q · filed 2021-10-29 |
| 2020-06-30 | $12.75B 10-Q · filed 2021-07-28 |
| 2020-03-31 | $13.12B 10-Q · filed 2021-04-28 |
| 2019-12-31 | $12.81B 10-K · filed 2022-02-11 |
| 2019-09-30 | $12.31B 10-Q · filed 2020-10-30 |
| 2019-06-30 | $11.94B 10-Q · filed 2020-07-31 |
| 2019-03-31 | $11.69B 10-Q · filed 2020-05-01 |
| 2018-12-31 | $11.73B 10-K · filed 2021-02-11 |
| 2018-09-30 | $9.86B 10-Q · filed 2019-10-30 |
| 2018-06-30 | $9.46B 10-Q · filed 2019-07-26 |
| 2018-03-31 | $9.22B 10-Q · filed 2019-04-24 |
| 2017-12-31 | $9.98B 10-K · filed 2020-02-06 |
| 2016-12-31 | $9.55B 10-K · filed 2019-02-07 |
| 2015-12-31 | $8.51B 10-K · filed 2018-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |